BookHiroshi Toyama, Yaming Li, Jun Hatazawa, Guang Huang, Kazuo Kubota, editors.
Contents:
1.2.3 Foam Cell Formation and FDG Uptake
1.2.4 Polarization of Macrophages and Uptake of FDG
1.2.5 Monitoring of the Therapeutic Effect
1.2.6 Comparison with Other PET Tracers
1.3 PET Imaging in Animal Model of Neuroinflammation 1
1.3.1 Introduction
1.3.2 Current Standard of Neuroinflammation Imaging
1.3.3 Alternative Molecular Targets for Microglia Imaging
1.4 PET Imaging in Animal Models of Neuroinflammation 2
1.4.1 Introduction
1.4.2 Brain Ischemia Model
1.4.3 Traumatic Brain Injury Model
1.4.4 Alzheimer's Disease Model 1.4.5 Other Models of Neuroinflammation
1.4.6 New PET Tracer for Neuroinflammation
1.4.7 Conclusion
1.5 PET Imaging of Inflammation in the Peripheral System with [18F]FEDAC, a Radioligand for Translocator Protein (18 kDa)
1.5.1 Introduction
1.5.2 PET Imaging and Quantitative Analysis of TSPO in Rat Peripheral Tissues
1.5.3 TSPO in Lung Inflammation
1.5.4 TSPO in Nonalcoholic Fatty Liver Disease
1.5.5 TSPO in Liver Damage
1.5.6 TSPO in Liver Fibrosis
1.5.7 TSPO in Multiple Sclerosis
1.5.8 TSPO in Rheumatic Arthritis
1.5.9 Conclusion 1.6 Role of Microglia in Neuroinflammation
1.6.1 Introduction
1.6.2 Microglia Diversity
1.6.3 Microglia and Neuroinflammation
1.6.4 Existence of Nontoxic Activated Form of Microglia in the Brain
1.6.5 Direct Evidence of Neuroprotection by Microglia in the Brain
1.6.6 Toxic Transformation of Microglia by Nef Protein Introduction
1.6.7 CNS Cytokine Network
1.7 Application of Preclinical PET Imaging for Infectious Diseases
1.7.1 Introduction
1.7.2 Imaging Laboratory for Infectious Diseases
1.7.3 PET Imaging with Infectious Small Animals
References 2: FDG-PET/CT in Patients with Inflammation or Fever of Unknown Origin (IUO and FUO)
2.1 Role of FDG-PET/CT in the Diagnosis of Fever or Inflammation of Unknown Origin (FUO/IUO)
2.1.1 What Is FUO?
2.1.2 What Is IUO?
2.1.3 Why FDG-PET/CT for FUO/IUO?
2.1.4 Results of FDG-PET/CT for FUO/IUO
2.1.5 Factors Affecting the Results
2.1.5.1 Disease Prevalence and Positivity
2.1.5.2 Markers of Inflammation
2.1.5.3 Structured Evaluation FUO/IUO
2.1.6 Conclusion
2.2 Systematic Review and Meta-Analysis in FDG-PET/CT for Inflammatory Diseases
2.2.1 Introduction